Ardent Health Partners Inc (NYSE:ARDT) does about 493.42K shares in volume on a normal day but saw 1483751 shares change hands in the recent trading day. The company now has a market cap of 2.65B USD. Its current market price is $18.58, marking an increase of 6.05% compared to the previous close of $17.52. The 52 week high reached by this stock is $18.16 whilst the lowest price level in 52 weeks is $15.00. The script in recent trading has seen the stock touch a high of $27 and a low of $20.
Ardent Health Partners Inc (ARDT) has a 20-day trading average at $16.89 and the current price is 2.31% off the 52-week high compared with 23.87% distance from its 52-week low. If we look at the stock’s price movements over the week, volatility stands at 4.25%, which increases to 5.35% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 67.79 to suggest the stock is neutral.
The consensus objective for the share price is $22.30, suggesting that the stock has a potential upside of 16.68% over the period. The median price target is 13.58% away from the current levels at $21.5.
#####
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 12, 2024 when Truist initiated the stock to “Buy” and issued a price target of $21. RBC Capital Mkts initiated its price target at $23.
The current price level is 10.52%, 10.35%, and 10.35% away from its SMA20, SMA50, and SMA200 respectively, with the ARDT price moving above the 50-day SMA on current market day. Ardent Health Partners Inc (ARDT) stock is up 7.09% over the week and 6.72% over the past month. Its price is 15.69% year-to-date.
The stock last released its quarterly earnings report for quarter ended 6/30/2024, with the company’s earnings per share (EPS) of 0.34 above consensus estimates by 0.04. The company’s next earnings report forecasts estimating quarterly EPS at 0.29 and 1.21 for whole year. Expected sales for next quarter are $1.48B, which analysts say will come at $5.84B for the current fiscal year and next year at $6.3B. In addition, estimates put the company’s current quarterly revenue at an average of $1.46B.
Its 12-month price target is $21.5. To reach the target analysts have set, the stock logically needs to grow 16.68 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $20, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $27.
Outstanding shares total 143.26M with insiders holding 22.91% of the shares and institutional holders owning 60.73% of the company’s common stock. Price to book ratio is 3.59.
#####
